8-K: Oscar Health Announces Results of 2024 Annual Stockholders Meeting

Oscar Health held its 2024 Annual Meeting of Stockholders on June 6, 2024, where all director nominees were elected and proposals regarding the appointment of auditors and executive compensation were approved.

Summary

• Oscar Health held its 2024 Annual Meeting of Stockholders on June 6, 2024.
• As of the record date of April 10, 2024, there were 201,466,384 shares of Class A common stock and 35,514,201 shares of Class B common stock outstanding.
• Each share of Class A common stock was entitled to one vote, and each share of Class B common stock was entitled to 20 votes.
• A total of 862,222,532 votes were represented at the meeting, constituting a quorum.
• Ten director nominees were elected to hold office until the 2025 Annual Meeting.
• The appointment of PricewaterhouseCoopers LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2024, was ratified.
• The compensation of the company's named executive officers was approved on an advisory basis.

Sentiment

Score: 8

Explanation: The document reflects a routine and successful annual meeting with all proposals passing, indicating a positive sentiment.

Positives

• All director nominees were successfully elected.
• The appointment of the independent auditor was ratified.
• Executive compensation was approved, indicating shareholder support.
• A quorum was achieved at the meeting, ensuring the validity of the votes.

Industry Context

This announcement is a routine update following the company's annual meeting, which is a standard practice for publicly traded companies. The results indicate shareholder alignment with the board's recommendations.

Comparison to Industry Standards

• The election of directors and ratification of auditors are standard procedures for publicly traded companies like Oscar Health.
• The high level of votes in favor of the proposals suggests a typical level of shareholder support, which is common in the industry.
• The advisory vote on executive compensation is also a standard practice, and the results are within the expected range for similar companies.

Stakeholder Impact

• Shareholders have successfully elected the board of directors and approved the auditor and executive compensation.
• The results of the meeting provide transparency to stakeholders regarding the company's governance.

Next Steps

• The newly elected directors will serve until the 2025 Annual Meeting.
• PricewaterhouseCoopers LLP will serve as the independent auditor for the fiscal year ending December 31, 2024.

Key Dates

Keywords

Annual Meeting, Stockholders, Director Election, Auditor Ratification, Executive Compensation, Voting Results, Oscar Health